Alger Health Sciences Portfolio

Scorecard
2 / 5 Stars
Lipper
1 1 5 3 2
Zacks Investment Research
2 (Buy)
Standard & Poor's
2 / 5 Stars
TheStreet.com
A- (Buy)

Fund Holdings

Asset Allocation

% Long % Net
Cash 3.85 3.85
Stocks 78.26 78.26
Bonds 0.0 0.0
Other 0.0 0.0
Foreign Bonds 0.0 0.0
Foreign Stocks 17.89 17.89
Convertible 0.0 0.0
Preferred 0.0 0.0

Updated 11.30.2013

Top 10 Holdings

Performance as of 02.28.2014

Portfolio as of 11.30.2013

Ticker YTD Return % % Net Assets
Pfizer Inc PFE 5.26 9.59
Gilead Sciences Inc GILD 8.46 6.91
Actavis PLC ACT 30.25 5.46
Biogen Idec Inc BIIB 21.04 4.73
Roche Holding AG RHHVF 4.05 3.62
AbbVie Inc ABBV -4.39 3.05
Bristol-Myers Squibb Company BMY 0.64 2.96
HCA Holdings Inc HCA 8.34 2.87
Merck & Co Inc MRK 12.73 2.68
Valeant Pharmaceuticals International Inc VRX 22.13 2.59